Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 49, Issue 14, Pages 4055-4058Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm0605029
Keywords
-
Categories
Ask authors/readers for more resources
Discovery of 5-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2yl)-4,5-dihydroisoxazole-3-carboxamides as a new class of malonyl-coenzyme A decarboxylase (MCD) inhibitors is described. tert-Butyl 3-(5-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-4,5-dihydroisoxazole-3-carboxamido) butanoate (5, CBM-301940) exhibited excellent potency and in vivo PK/ADME properties. It is the most powerful stimulant of glucose oxidation reported to date in isolated working rat hearts. Compound 5 improved the cardiac efficiency and function in a rat heart global ischemia/reperfusion model, suggesting MCD inhibitors may be useful for the treatment of ischemic heart diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available